Bukwang Pharmaceutical Statistics

Total Valuation

KRX:003000 has a market cap or net worth of KRW 265.60 billion. The enterprise value is 215.41 billion.

Market Cap	265.60B
Enterprise Value	215.41B

Important Dates

The next estimated earnings date is Tuesday, May 13, 2025.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

KRX:003000 has 68.45 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	68.45M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	19.14%
Owned by Institutions (%)	2.95%
Float	47.58M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.66
PB Ratio	1.09
P/TBV Ratio	1.12
P/FCF Ratio	8.19
P/OCF Ratio	7.73
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 35.51, with an EV/FCF ratio of 6.64.

EV / Earnings	-81.55
EV / Sales	1.35
EV / EBITDA	35.51
EV / EBIT	109.86
EV / FCF	6.64

Financial Position

The company has a current ratio of 5.76, with a Debt / Equity ratio of 0.33.

Current Ratio	5.76
Quick Ratio	4.37
Debt / Equity	0.33
Debt / EBITDA	13.88
Debt / FCF	2.45
Interest Coverage	0.25

Financial Efficiency

Return on equity (ROE) is -1.45% and return on invested capital (ROIC) is 0.32%.

Return on Equity (ROE)	-1.45%
Return on Assets (ROA)	0.25%
Return on Invested Capital (ROIC)	0.32%
Return on Capital Employed (ROCE)	0.48%
Revenue Per Employee	288.97M
Profits Per Employee	-4.77M
Employee Count	554
Asset Turnover	0.40
Inventory Turnover	1.75

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -35.42% in the last 52 weeks. The beta is 0.95, so KRX:003000's price volatility has been similar to the market average.

Beta (5Y)	0.95
52-Week Price Change	-35.42%
50-Day Moving Average	4,449.40
200-Day Moving Average	4,844.53
Relative Strength Index (RSI)	39.03
Average Volume (20 Days)	141,144

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:003000 had revenue of KRW 160.09 billion and -2.64 billion in losses. Loss per share was -39.00.

Revenue	160.09B
Gross Profit	74.06B
Operating Income	1.62B
Pretax Income	-2.97B
Net Income	-2.64B
EBITDA	5.72B
EBIT	1.62B
Loss Per Share	-39.00

Full Income Statement

Balance Sheet

The company has 130.09 billion in cash and 79.42 billion in debt, giving a net cash position of 50.67 billion or 740.15 per share.

Cash & Cash Equivalents	130.09B
Total Debt	79.42B
Net Cash	50.67B
Net Cash Per Share	740.15
Equity (Book Value)	244.15B
Book Value Per Share	3,559.67
Working Capital	168.34B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 34.36 billion and capital expenditures -1.94 billion, giving a free cash flow of 32.42 billion.

Operating Cash Flow	34.36B
Capital Expenditures	-1.94B
Free Cash Flow	32.42B
FCF Per Share	473.65

Full Cash Flow Statement

Margins

Gross margin is 46.27%, with operating and profit margins of 1.01% and -1.65%.

Gross Margin	46.27%
Operating Margin	1.01%
Pretax Margin	-1.85%
Profit Margin	-1.65%
EBITDA Margin	3.58%
EBIT Margin	1.01%
FCF Margin	20.25%

Dividends & Yields

KRX:003000 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-0.99%
FCF Yield	12.21%

Dividend Details

Stock Splits

The last stock split was on December 29, 2020. It was a forward split with a ratio of 1.1.

Last Split Date	Dec 29, 2020
Split Type	Forward
Split Ratio	1.1

Scores

KRX:003000 has an Altman Z-Score of 3.42.

Altman Z-Score	3.42
Piotroski F-Score	n/a